Recent studies have suggested the use of lipoproteins as an adjuvant treatment of lethal gram-negative infections. However, other important microorganisms for the etiology of sepsis, such as Candida species, grow better in lipid-rich environments. We investigated the effect of hyperlipoproteinemia on systemic candidiasis in low-density-lipoprotein-receptor-deficient (LDLR^" ) mice, in which the loss of the receptor results in a seven-to ninefold-higher plasma LDL level than that in their wild-type littermates (C57BL/6J). LDLR" /_ mice died earlier, and the outgrowth of Candida albicans in the kidneys and livers of LDLR~/_ mice was significantly higher compared with that of controls. After infection, circulating cytokine concentrations were significantly higher in LDLR-/" mice. In vitro, C. albicans grew better in plasma samples of LDLR_;~ mice than in control plasma samples and peritoneal macrophages of LDLR~y" mice challenged with heat-killed C. albicans pro duced more cytokines than did those of controls. This latter phenomenon was probably due to increased binding of yeast cells to macrophages of LDLR~/_ mice. These data suggest that hyperlipoproteinemia is deleterious in systemic candidiasis.
Acute disseminated candidiasis is a life-threatening condi tion that occurs predominantly in immunocompromised hosts. The mortality rate associated with disseminated candidiasis is high (31) , and the incidence of this disease has increased in recent years (1, 3) . Candida albicans ranks fourth among the organisms most frequently isolated from blood cultures in the United States (1) . Clinically, systemic candidiasis sometimes mimics gram-negative sepsis. Viable Candida cells and cell wall constituents are able to induce the synthesis of proinflammatory cytokines in vitro (13, 14, 18) , similar to gram-negative bacteria and their lipopolysaccharide (LPS) component (23) . However, the role of these cytokines in systemic candidiasis is probably beneficial rather than deleterious (20, 26) . In con trast, the induction of proinflammatory cytokines, such as interleukin-la (IL-la) and IL-1(3 and tumor necrosis factor al pha (TNF-a), is merely a deleterious event in gram-negative sepsis (4) and treatment aimed at blocking cytokine action has proved beneficial in various experimental models (2, 27, 30) . In sepsis in humans, anticytokine strategies have not been suc cessful so far. This is the reason why the focus of several recent studies has been on the capacity of lipoproteins in the circu lation to bind and neutralize LPS and subsequently inhibit cytokine production. Preincubation of LPS with lipoproteins prior to injection into animals decreased mortality after LPS injection (28). Moreover, in vivo infusion of lipoproteins mark edly reduced cytokinemia and mortality after LPS administra tion (11) . Transgenic mice that express human apolipoprotein A-l at high levels and have elevated plasma high-density-lipoprotein concentrations are protected against LPS challenge (17) . Furthermore, low-density-lipoprotein-receptor-deficient (LDLR-/~) mice, in which the plasma LDL concentration is increased seven to nine times ( 12), were significantly protected not only against lethal endotoxemia but also against lethal Klebsiella pneumoniae infection (21), In addition, an infusion of lipoproteins in rats protected the animals against mortality due to gram-negative bacterial sepsis in a model of cecal liga tion and puncture (24) . Taken together, these experiments demonstrate the capacity of lipoproteins to neutralize LPS and support their potential use as adjuvants in the therapy of sepsis.
On the other hand, earlier in vitro studies of lipid-containing parenteral solutions introduced for clinical use suggested that certain microorganisms, such as C. albicans and Staphylococcus aureus, grew better in a lipid-rich environment (5, 9, 16) . Therefore, it is important to know the effect of hyperlipopro teinemia on the outcome of a systemic infection with these organisms before suggesting the application of infusion with lipoproteins as an adjuvant therapy in sepsis. In the present study, we assessed the influence of hyperlipoproteinemia on experimental systemic candidiasis in LDLR 1 mice.
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The outgrowth of micro organ isms from the livers, spleens, and kidneys of ani mals was quantified on days 1 and 3 after C. albicans injection. For this purpose, the organs were removed aseptically, weighed, and homogenized in sterile saline in a tissue grinder. The number of viable C. albicans cells in tissue samples was determined by plating serial dilutions on Sabouraud dextrose agar plates as described previously (15) , and CFU were counted after overnight incubation at 37°C. The results were expressed as the log CFU per gram of tissue.
Ex vivo cytokine production. Resident peritoneal macrophages were harvested by rinsing the peritoneal cavity aseptically with cold phosphate-buffered saline containing 0.38% (wt/vol) sodium citrate. After centrifugation, cells were resus pended in RPMI 1640 (Dutch modification; Flow Laboratories, Irvine, United Kingdom) containing 1 mM pyruvate, 2 mM L-glutamine, and 100 jjig of gentamicin per ml and incubated for 1 h at 37Ü C (105/well) in 96-well microtiter plates (Costar Corporation, Cambridge, Mass.). Nonadherent cells were discarded, and the remaining cell population consisted of more than 90% macrophages, as assessed by light microscopy. Heat-killed (30 min, 100°C) C. albicans cells were washed three times in RPMI 1640 (final concentration, 2 X 107 CFU/ml), Two hundred microliters of suspension containing 106 microorganisms in RPMI 1640 was added to peritoneal macrophages and incubated at 37°C. After 24 h, supernatants were collected and stored at -70°C until assayed. To the remaining macrophages» 200 jxl of RPMI 1640 was added, and cells were disrupted by three freeze-thaw cycles to determine the cell-associated cytokine contents. The sam ples were stored at -70°C until assayed.
Cytokine measurements. TNF-a, IL-la, and IL-lfJ concentrations were de termined by specific radioimmunoassays developed in our laboratory, as previ ously described (21) .
C. albicans binding studies. C. albicans cells were radioiodinated by the iodogen method (8) with minor modifications. Briefly, 108 C. albicans cells in 50 mM phosphate buffer (pH 7.2) were incubated in an iodogen-coated vial (20 fj.g/100 jjiI) in the presence of 300 (xCi of Na125I (specific activity, 15 mCi/jxg; Amersham) in a total volume of 100 p.I. After 15 min of incubation, the suspension was washed three times with phosphate-buffered saline and resuspended in RPMI 1640 containing 1 mM of pyruvate, 2 mM of L-glutamine, and 100 fig of gentamicin per ml (labelling efficiency, 45%). Peritoneal macrophages from LDLR~/_ and control mice were collected as described above. Macrophages (2 X 105) were incubated with 10fi CFU of radioiodinated C. albicans in a total volume of 200 [xl of RPMI 1640 at 37°C in 96-well microtiter plates. After 5, 15, and 30 min, the supernatant was discarded and the radioactivity associated with adherent cells was measured with a gamma counter. Nonspecific binding was determined in wells in which C. albicans cells were incubated in the absence of macrophages. Total binding of C, albicans cells to macrophages (including both specific binding to receptors and nonspecific binding through membrane hydrophobicity or other nonspecific interactions) was determined by subtracting the binding of C albi cans cells to plastic from total counts.
Growth of C. albicans in vitro. To investigate whether the growth of C. albicans in the plasma of LDLR ~/_ mice is similar to that in plasma of control mice, 2 x 104 CFU of C. albicans were incubated in plasma samples obtained from LDLR"7" and control mice diluted 50% with Sabouraud broth in 10-ml glass tubes (Hospidex, Nieuwkoop, The Netherlands) in a final volume of 2 ml After 12 and 24 h of incubation at 37°C, aliquots of 0.1 ml were removed, serial dilutions were plated on Sabouraud agar, and CFU were counted after overnight incubation at 37°C. The adherence of C. albicans cells to tubes was checked and found to be less than 1% of total counts.
Determination of plasma lipids. Cholesterol and triglycerides were deter mined by enzymatic methods with a Hitachi 747 analyzer.
Statistical analysis. The survival curves for control and LDLR ' mice were compared by the Kaplan-Meyer log rank test. Differences in concentrations of cytokines and in organ counts of microorganisms were analyzed by the MannWhitney U test. Differences were considered significant at P < 0.05. All exper iments were performed at least twice.
7 -RESULTS C. albicans infection. Plasma cholesterol concentrations de creased significantly during C. albicans infection in both mouse strains (P < 0.05) but remained three to four times higher in LDLR"7" mice than in control mice (P < 0.01) ( Table 1 ). The initial plasma triglyceride levels in LDLR~7~ mice were two times higher than those of controls (P < 0.01). Four hours after infection, triglyceride levels decreased significantly in LDLR-7" mice (P < 0.05) and only marginally in control animals (P > 0.05) ( Table 1) . The triglyceride levels 4 h after C. albicans infection did not differ significantly between the two mouse strains (P > 0.05) ( Table 1 ). After i.v. injection of either 106 or 107 CFU of C. albicans, LDLR"7" mice died significantly earlier than did control animals (P < 0.05) ( outgrowth in the kidneys of LDLR~7" mice was significantly higher compared with that of controls; 3 days after infection, outgrowth of C. albicans was increased in both the kidneys and livers of LDLR"7" mice ( Table 2) . No difference in the out growth of C. albicans in the spleen was detected between the two mouse strains ( Table 2) .
Four hours after infection, plasma TNF-a concentrations were below the detection limit and IL-la concentrations were higher in LDLR"7" mice than in controls (140 ± 22 versus 78 ± 48 pg/ml, respectively; P < 0.05). Circulating IL-lp con centrations were similar in both strains (56 ± 29 versus 37 ± 28 pg/ml, respectively; P > 0.05). Plasma TNF-a concentrations were significantly higher in LDLR"7" mice compared with those of control animals at both 24 (42 ± 5 versus 18 ± 4 pg/ml, respectively; P < 0,01) and 72 (302 ± 237 versus 98 ± 58 pg/ml, respectively; P < 0.02) h after infection (Fig. 2) . No differences in plasma IL-la and IL-1|3 concentrations were observed at these time points (Fig. 2) .
In vitro cytokine production. We investigated the capacity of peritoneal macrophages of both mouse strains to produce cy tokines when stimulated in vitro with heat-killed C. albicans. Compared with those of controls, the TNF-a concentrations in supernatants from macrophages of LDLR"7~ mice were sig nificantly higher (Fig. 3a) . The IL-la and IL-lp concentrations were only marginally increased (Fig. 3a) . The cell-associated IL-la concentration was significantly increased in macro phages of LDLR"7" mice, but the cell-associated TNF-a and IL-1 (3 concentrations did not differ between the two mouse strains (Fig. 3b) .
C. albicans b in d in g . To investigate the total binding of C. albicans to macrophages from the two mouse strains, we incu bated radioiodixiated C. albicans cells with macrophages (5:1 ratio) and determined the amounts bound to macrophages after 5, 10, and 30 min of incubation. The binding of yeast cells to macrophages o f LDLR-/~ mice was increased and more rapid compared to that of control macrophages (Fig. 4) .
Growth of C. albicans in vitro. To investigate whether the outgrowth of C. albicans in the organs of LDLR"7" mice is due to enhanced growth of yeast cells in a lipoprotein-rich envi ronment, we compared the in vitro growth of 1G4 CFU of C, albicans in plasm a samples (diluted 1:1 with Sabouraud me dium) of L D L R "/" mice and controls, The capacity of LDLR""7'' plasm a to inhibit the outgrowth of C. albicans was decreased com pared with that of control plasma, as shown by the growth of C. albicans in the two types of plasma samples after 12 [(7.2 ± 2*4) X 103 versus (2.4 ± 1.5) X 103 CFU/ml, respectively; P < 0.05] and 24 [(4.2 ± 1.6) X 103 versus (1.5 ± 1.0) X 103 CFU/ml, respectively; P < 0.05] h of incubation.
The main conclusion from the present study is that hyperli poproteinemia has deleterious effects on the outcome of se vere C. albicans infection, in contrast to gram-negative bacte rial infections. We have shown that LDLR~y~ mice, with seven-to nine-times-higher LDL levels, are more susceptible to C. albicans infection than are their wild-type littermates. The earlier mortality of LDLR~y" mice was associated with increased outgrowth of C. albicans in their organs, and these mice produced significantly more proinflammatory cytokines than did control mice.
In general, mortality after infection may be due to lethal cytokinemia or to functional impairment by the growth of microorganisms in the organs of an animal. The increased susceptibility of LDLR_/" mice to C. albicans is likely to be due to the latter mechanism, because C. albicans did not in duce an impressive cytokinemia. The hypothesis that cytokines are not responsible for the deaths of animals during G albicans infection is in agreement with studies showing that the stimu lation of neutrophils and macrophages by TNF and IL-1 en hanced their capability to kill C albicans cells (6, 29) , whereas anti-TNF antibodies (26) or pharmacologic inhibition of proin flammatory cytokines proved to be deleterious during severe C albicans infection (20) . Thus, proinflammatory cytokines seem to play a beneficial rather than a deleterious role in the defense against G albicans. It should be noted that despite the greater cytokine response, LDLR~y~ mice were not protected against C. albicans infection, probably due to the overwhelm ing outgrowth of yeast cells in their organs.
It may be hypothesized that the enhanced outgrowth of G albicans in the organs of LDLR"/_ mice is due to elevated lipoprotein concentrations. Normal serum has a candidicidal effect (22) , and as shown by in vitro growth experiments, this property was significantly decreased in plasma samples from LDLR"' " mice. This effect may be due to the use of lipopro teins as a nutrition factor by G albicans, as has been suggested by earlier studies showing increased growth of C. albicans in lipid-containing parenteral solutions compared with that in formulations without lipid contents (5, 9, 16) . Another possible mechanism by which lipoproteins could influence C. albicans growth is interaction with other plasma factors. We cannot exclude the possibility that plasma candidicicial factors, such as platelet microbicidal protein (32) and the calprotectin complex (19) , are bound and inactivated by lipoproteins.
The higher cytokine concentrations during infection in LDLR"7" mice, compared with those of controls, were prob ably at least in part a response of the host against enhanced C. albicans outgrowth in the organs of LDLR"7-mice. However, surprisingly, stimulated in vitro with heat-killed C. albicans, macrophages of LDLR"7" mice produced significantly more TNF-a and IL-la than macrophages of control mice did. Most likely, this was due to the observed increased binding of G albicans to macrophages of LDLR"7 mice compared with that of control macrophages. This phenomenon may be ex plained by the influence of constitutively increased lipoprotein concentrations in LDLRW" mice on the Candida-binding pro teins on macrophage, ft has been shown previously that hyper cholesterolemia is able to modify the number and clustering of other receptors, such as the LPS receptor CD 14 (7, 25) . Ear lier, we observed similar higher binding of radiolabelled LPS to macrophages of LDLR"7" mice, followed by higher cytokine production (21) . Thus, similar changes in the number and/or clustering of Crt/ififa/rt-binding proteins may facilitate the bind ing of C. albicans to macrophages of LDLR"7" mice, with a subsequent increase in cytokine production. Hyperlipoprotein emia could also modify the hydrophobicity of ceils, which may also influence the adherence of G albicans to macrophages, as has been shown for endothelial cells (10) , Which of these mechanisms is responsible for the observed increase in cyto kine production by macrophages of LDLR"7" mice is under study.
An alternative desirable experiment to our model in order to investigate the influence of hyperlipoproteinemia in G albi cans infection would have been to infuse lipoproteins into animals before and during infection. However, an infusion of lipoproteins into mice is not possible and other models of lipoprotein infusion in rabbits (11) and rats (24) are short-term models that are not suitable for sustained lipid infusion during systemic candidiasis. Therefore, the genetically modified mouse model is a good alternative for studying the in vivo effects of hyperlipoproteinemia in models of sustained infec tion.
In conclusion, hyperlipoproteinemia has deleterious effects on the course of acute disseminated G albicans infection, in contrast to its beneficial effect in gram-negative infection. Al though no epidemiological studies have been done to show a relationship between hyperlipoproteinemia and increased sus ceptibility to G albicans, an infusion of lipoproteins into a patient with disseminated candidiasis under the presumptive diagnosis of gram-negative sepsis may prove deleterious. These divergent effects of hyperlipoproteinemia should be taken into account when the use of lipoproteins as an adjuvant treatment of sepsis is considered.
